Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts.
about
Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatmentHypertrophic scars in a patient with Turner's syndrome treated with recombinant growth hormone.Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar.Genetics of keloid scarring.From scarless fetal wounds to keloids: molecular studies in wound healing.Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progressionOverexpression of mIGF-1 in keratinocytes improves wound healing and accelerates hair follicle formation and cycling in miceSphingosine may have cytotoxic effects via apoptosis on the growth of keloid fibroblasts.Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy.Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro.Sage transcript profiles in cultured human fetal fibroblasts, WI-38.Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids.Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.Characterization of proliferative effects of insulin, insulin analogues and insulin-like growth factor-1 (IGF-1) in human lung fibroblasts.The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?Human mesenchymal stem cells may be involved in keloid pathogenesis.Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways.IGF-I stimulates neurogenesis in the hypothalamus of adult rats.Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.Gene expression patterns in isolated keloid fibroblasts.Fibulin-5 regulates keloid-derived fibroblast-like cells through integrin beta-1.Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration.Phosphorylation of the ribosomal protein S6, a marker of mTOR (mammalian target of rapamycin) pathway activation, is strongly increased in hypertrophic scars and keloids.Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
P2860
Q24803687-49269AC5-263A-4A65-8E73-7448A8B78040Q33725897-BDB13C53-E262-4C3E-838D-EE7BD8F61C26Q33955598-2519ADD9-ED3F-4562-A48F-A4C40373F894Q34102567-6864A852-9454-4317-AAE6-79C72F02A32AQ34513143-A3B5EC0F-6E4B-4133-BEA6-05230A2EFFCEQ34616449-AC06B576-8692-455F-BB03-E67FAA518B95Q35583617-1AD4B112-C046-4CEA-B7E9-94568BA3EB0CQ35876800-3C7AE7C0-DF84-40B2-96E7-850A7E2543E1Q36943053-DC2379BA-3CA3-4A72-AB14-77F41A8FAF21Q38518339-4654B911-E7AB-4766-A18A-773DF3F8011CQ39836599-BFE654E1-7CAE-4011-8986-CF1ECA844FAEQ40666079-B74642F4-197C-4DBE-BE01-CF9E2A945893Q40840404-2D0C76E8-A385-4A94-A1A8-1AFCA851A5A0Q42438679-8EE3C170-FEFC-4832-93EA-A3787138A752Q42484504-A01B982D-F540-441C-ACD4-11E1568D1069Q42868968-40FE3DD7-83DF-4D8A-A4C5-C489C4509D3CQ43436232-DA548DA1-E380-4A05-9077-6FA995ACC11AQ43684142-B68F91A8-FDF1-4131-9822-EE58269EF20CQ47757836-A178F028-E904-41DE-8EE6-D290D09D2B0CQ48175097-A356D8E6-AB8B-4764-86C6-2A1BE187B29FQ50067894-DEB0762E-3913-4487-BA57-2374DCE2D055Q51584092-898D9FBF-273E-4D82-910E-2F504F01FFA4Q53460583-E3A302ED-2DD4-43E0-8971-724EC119B4C5Q53627288-F4BA58CE-8751-421C-8D7C-9FABAC2CA43FQ54310511-33958D85-423A-4CF4-B662-B3591417417AQ54345480-165EB05E-1004-4881-B7DC-E87549C6FC0CQ54548659-26E1EA07-1A70-47B2-BED8-448BF0ABC1D1
P2860
Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Overexpression of insulin-like ...... f cultured keloid fibroblasts.
@ast
Overexpression of insulin-like ...... f cultured keloid fibroblasts.
@en
type
label
Overexpression of insulin-like ...... f cultured keloid fibroblasts.
@ast
Overexpression of insulin-like ...... f cultured keloid fibroblasts.
@en
prefLabel
Overexpression of insulin-like ...... f cultured keloid fibroblasts.
@ast
Overexpression of insulin-like ...... f cultured keloid fibroblasts.
@en
P2093
P2860
P1476
Overexpression of insulin-like ...... f cultured keloid fibroblasts.
@en
P2093
Ishihara H
Murakami R
Yamashita S
Yoshimoto H
P2860
P304
P356
10.1016/S0002-9440(10)65335-7
P407
P577
1999-03-01T00:00:00Z